Cementos Bio Bio S.A. (SNSE:CEMENTOS)

Cementos Bio Bio Income Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	362,380	359,565	349,104	334,004	289,468	242,586
Revenue Growth (YoY)	0.48%	3.00%	4.52%	15.38%	19.33%	-9.69%
Cost of Revenue	226,782	222,102	219,413	228,479	186,287	146,484
Gross Profit	135,598	137,462	129,692	105,525	103,181	96,102
Selling, General & Admin	98,968	97,800	94,685	94,110	86,095	73,039
Other Operating Expenses	44.33	445.7	120.09	-	-	-
Operating Expenses	99,013	98,245	94,805	94,110	86,095	73,039
Operating Income	36,585	39,217	34,887	11,415	17,086	23,062
Interest Expense	-10,200	-10,708	-14,353	-11,141	-3,561	-4,038
Interest & Investment Income	808.05	1,490	1,210	1,063	598.99	285.22
Currency Exchange Gain (Loss)	1,667	3,877	434.34	-1,311	1,425	-1,248
Other Non Operating Income (Expenses)	2,391	1,260	3,574	1,954	2,114	385.14
EBT Excluding Unusual Items	31,251	35,136	25,752	1,980	17,662	18,447
Gain (Loss) on Sale of Assets	3,123	5,265	556.51	3,427	8,655	1,178
Asset Writedown	-789.34	-508.61	-584.07	-2,550	-988.27	-3,478
Other Unusual Items	-	-	-	-	685.41	43.04
Pretax Income	33,582	40,970	26,622	5,635	33,911	16,263
Income Tax Expense	6,490	8,571	3,812	-4,926	6,885	2,351
Earnings From Continuing Operations	27,092	32,399	22,809	10,561	27,026	13,912
Minority Interest in Earnings	16.29	28.34	-12.25	-1.13	-146.9	-149.47
Net Income	27,108	32,427	22,797	10,560	26,879	13,763
Net Income to Common	27,108	32,427	22,797	10,560	26,879	13,763
Net Income Growth	-17.61%	42.24%	115.88%	-60.71%	95.30%	5.03%
Shares Outstanding (Basic)	265	264	264	264	264	264
Shares Outstanding (Diluted)	265	264	264	264	264	264
EPS (Basic)	102.49	122.73	86.28	39.97	101.73	52.09
EPS (Diluted)	102.49	122.73	86.28	39.97	101.73	52.09
EPS Growth	-17.70%	42.24%	115.88%	-60.71%	95.30%	5.03%
Free Cash Flow	56,291	54,336	24,086	9,374	3,860	24,226
Free Cash Flow Per Share	212.82	205.65	91.16	35.48	14.61	91.69
Dividend Per Share	-	-	36.000	12.000	48.000	42.000
Dividend Growth	-	-	200.00%	-75.00%	14.29%	162.50%
Gross Margin	37.42%	38.23%	37.15%	31.59%	35.64%	39.62%
Operating Margin	10.10%	10.91%	9.99%	3.42%	5.90%	9.51%
Profit Margin	7.48%	9.02%	6.53%	3.16%	9.29%	5.67%
Free Cash Flow Margin	15.53%	15.11%	6.90%	2.81%	1.33%	9.99%
EBITDA	47,990	53,550	48,082	24,159	30,270	34,832
EBITDA Margin	13.24%	14.89%	13.77%	7.23%	10.46%	14.36%
D&A For EBITDA	11,405	14,332	13,195	12,744	13,184	11,770
EBIT	36,585	39,217	34,887	11,415	17,086	23,062
EBIT Margin	10.10%	10.91%	9.99%	3.42%	5.90%	9.51%
Effective Tax Rate	19.33%	20.92%	14.32%	-	20.30%	14.45%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.